Direct screening for chromatin status on DNA barcodes in yeast delineates the regulome of H3K79 methylation by Dot1

Abstract

Given the frequent misregulation of chromatin in cancer, it is important to understand the cellular mechanisms that regulate chromatin structure. However, systematic screening for epigenetic regulators is challenging and often relies on laborious assays or indirect reporter read-outs. Here we describe a strategy, Epi-ID, to directly assess chromatin status in thousands of mutants. In Epi-ID, chromatin status on DNA barcodes is interrogated by chromatin immunoprecipitation followed by deep sequencing, allowing for quantitative comparison of many mutants in parallel. Screening of a barcoded yeast knock-out collection for regulators of histone H3K79 methylation by Dot1 identified all known regulators as well as novel players and processes. These include histone deposition, homologous recombination, and adenosine kinase, which influences the methionine cycle. Gcn5, the acetyltransferase within the SAGA complex, was found to regulate histone methylation and H2B ubiquitination. The concept of Epi-ID is widely applicable and can be readily applied to other chromatin features.

Article and author information

Author details

  1. Hanneke Vlaming

    Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1743-6428
  2. Thom M Molenaar

    Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands
    Competing interests
    No competing interests declared.
  3. Tibor van Welsem

    Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands
    Competing interests
    No competing interests declared.
  4. Deepani W Poramba-Liyanage

    Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands
    Competing interests
    No competing interests declared.
  5. Desiree E Smith

    Department of Clinical Chemistry, Metabolic Laboratory, VU University Medical Center, Amsterdam, Netherlands
    Competing interests
    No competing interests declared.
  6. Arno Velds

    Central Genomics Facility, Netherlands Cancer Institute, Amsterdam, Netherlands
    Competing interests
    No competing interests declared.
  7. Liesbeth Hoekman

    Mass Spectrometry/Proteomics Facility, Netherlands Cancer Institute, Amsterdam, Netherlands
    Competing interests
    No competing interests declared.
  8. Tessy Korthout

    Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands
    Competing interests
    No competing interests declared.
  9. Sjoerd Hendriks

    Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands
    Competing interests
    No competing interests declared.
  10. AF Maarten Altelaar

    Mass Spectrometry/Proteomics Facility, Netherlands Cancer Institute, Amsterdam, Netherlands
    Competing interests
    No competing interests declared.
  11. Fred van Leeuwen

    Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands
    For correspondence
    fred.v.leeuwen@nki.nl
    Competing interests
    Fred van Leeuwen, The Netherlands Cancer Institute and FvL are entitled to royalties that may result from licensing the yeast H2BK123ub-specific monocloncal antibody according to IP policies of the Netherlands Cancer Institute..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7267-7251

Funding

Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO-VICI-016.130.627)

  • Fred van Leeuwen

KWF Kankerbestrijding (KWF NKI2014-7232)

  • Fred van Leeuwen

KWF Kankerbestrijding (KWF NKI2009-4511)

  • Fred van Leeuwen

Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO-VIDI 723.012.102)

  • AF Maarten Altelaar

National Roadmap Large-scale Research Facilities of The Netherlands (184.032.201)

  • Liesbeth Hoekman
  • AF Maarten Altelaar

Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NCI-KIEM-731.013.102)

  • Fred van Leeuwen

Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NCI-LIFT-731.015.405)

  • Fred van Leeuwen

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Cynthia Wolberger, Johns Hopkins University, United States

Version history

  1. Received: June 17, 2016
  2. Accepted: December 2, 2016
  3. Accepted Manuscript published: December 6, 2016 (version 1)
  4. Version of Record published: December 22, 2016 (version 2)

Copyright

© 2016, Vlaming et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,818
    views
  • 609
    downloads
  • 22
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Hanneke Vlaming
  2. Thom M Molenaar
  3. Tibor van Welsem
  4. Deepani W Poramba-Liyanage
  5. Desiree E Smith
  6. Arno Velds
  7. Liesbeth Hoekman
  8. Tessy Korthout
  9. Sjoerd Hendriks
  10. AF Maarten Altelaar
  11. Fred van Leeuwen
(2016)
Direct screening for chromatin status on DNA barcodes in yeast delineates the regulome of H3K79 methylation by Dot1
eLife 5:e18919.
https://doi.org/10.7554/eLife.18919

Share this article

https://doi.org/10.7554/eLife.18919

Further reading

    1. Biochemistry and Chemical Biology
    2. Chromosomes and Gene Expression
    Ramona Weber, Chung-Te Chang
    Research Article

    Recent findings indicate that the translation elongation rate influences mRNA stability. One of the factors that has been implicated in this link between mRNA decay and translation speed is the yeast DEAD-box helicase Dhh1p. Here, we demonstrated that the human ortholog of Dhh1p, DDX6, triggers the deadenylation-dependent decay of inefficiently translated mRNAs in human cells. DDX6 interacts with the ribosome through the Phe-Asp-Phe (FDF) motif in its RecA2 domain. Furthermore, RecA2-mediated interactions and ATPase activity are both required for DDX6 to destabilize inefficiently translated mRNAs. Using ribosome profiling and RNA sequencing, we identified two classes of endogenous mRNAs that are regulated in a DDX6-dependent manner. The identified targets are either translationally regulated or regulated at the steady-state-level and either exhibit signatures of poor overall translation or of locally reduced ribosome translocation rates. Transferring the identified sequence stretches into a reporter mRNA caused translation- and DDX6-dependent degradation of the reporter mRNA. In summary, these results identify DDX6 as a crucial regulator of mRNA translation and decay triggered by slow ribosome movement and provide insights into the mechanism by which DDX6 destabilizes inefficiently translated mRNAs.

    1. Chromosomes and Gene Expression
    Marwan Anoud, Emmanuelle Delagoutte ... Jean-Paul Concordet
    Research Article

    Tardigrades are microscopic animals renowned for their ability to withstand extreme conditions, including high doses of ionizing radiation (IR). To better understand their radio-resistance, we first characterized induction and repair of DNA double- and single-strand breaks after exposure to IR in the model species Hypsibius exemplaris. Importantly, we found that the rate of single-strand breaks induced was roughly equivalent to that in human cells, suggesting that DNA repair plays a predominant role in tardigrades’ radio-resistance. To identify novel tardigrade-specific genes involved, we next conducted a comparative transcriptomics analysis across three different species. In all three species, many DNA repair genes were among the most strongly overexpressed genes alongside a novel tardigrade-specific gene, which we named Tardigrade DNA damage Response 1 (TDR1). We found that TDR1 protein interacts with DNA and forms aggregates at high concentration suggesting it may condensate DNA and preserve chromosome organization until DNA repair is accomplished. Remarkably, when expressed in human cells, TDR1 improved resistance to Bleomycin, a radiomimetic drug. Based on these findings, we propose that TDR1 is a novel tardigrade-specific gene conferring resistance to IR. Our study sheds light on mechanisms of DNA repair helping cope with high levels of DNA damage inflicted by IR.